Krka products have been present in the Greek pharmaceutical market through partners since 2009. In 2020, Krka established the company Krka Hellas E.P.E., located in Athens, which started promoting Krka products the following year. We first launched cardiology and gastroenterology products such as Pitavador (pitavastatin), Rosuvador (rosuvastatin), Esolib (esomeprazole) and Zoletad (lansoprazole). In the near future, Krka plans to expand its business operations and exploit market opportunities further. The story of Krka in Greece has only just begun.
Λίστα Προϊόντων Krka Hellas (List of products)